These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6159988)

  • 41. Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.
    Coates A; Mackay IR; Crawford M
    Cell Immunol; 1974 Jun; 12(3):370-81. PubMed ID: 4142423
    [No Abstract]   [Full Text] [Related]  

  • 42. Experimental allergic encephalomyelitis and cellular immunity in the Lewis rat.
    Vandenbark AA; Hinrichs DJ
    Cell Immunol; 1974 Apr; 12(1):85-93. PubMed ID: 4142415
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunomodulation of relapsing experimental allergic encephalomyelitis.
    Lublin FD
    Neurology; 1984 Dec; 34(12):1615-7. PubMed ID: 6209597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of lethal experimental allergic encephalomyelitis in nonhuman primates and guinea pigs with human glioblastoma multiforme tissue.
    Bigner DD; Pitts OM; Wikstrand CJ
    J Neurosurg; 1981 Jul; 55(1):32-42. PubMed ID: 6165811
    [No Abstract]   [Full Text] [Related]  

  • 46. Protection against experimental allergic encephalomyelitis.
    Teitelbaum D; Webb C; Meshorer A; Arnon R; Sela M
    Nature; 1972 Dec; 240(5383):564-6. PubMed ID: 4119624
    [No Abstract]   [Full Text] [Related]  

  • 47. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis.
    Raine CS; Traugott U; Stone SH
    Science; 1978 Aug; 201(4354):445-8. PubMed ID: 78524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.
    Hempel K; Freitag A; Freitag B; Endres B; Mai B; Liebaldt G
    Int Arch Allergy Appl Immunol; 1985; 76(3):193-9. PubMed ID: 2579028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer.
    Teitelbaum D; Webb C; Bree M; Meshorer A; Arnon R; Sela M
    Clin Immunol Immunopathol; 1974 Nov; 3(2):256-62. PubMed ID: 4141659
    [No Abstract]   [Full Text] [Related]  

  • 50. Some observations on the role of circulating antibody in protection against experimental allergic encephalomyelitis.
    Caspary EA; Sinden RE; Field EJ
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):454-60. PubMed ID: 4228969
    [No Abstract]   [Full Text] [Related]  

  • 51. Cell-mediated immunity in experimental allergic encephalomyelitis: cross reactivity between myelin basic protein and mycobacteria antigens.
    Vandenbark AA; Burger DR; Vetto RM
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):1233-6. PubMed ID: 48264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide.
    Hoffman PM; Gaston DD; Spitler LE
    Clin Immunol Immunopathol; 1973 Apr; 1(3):364-71. PubMed ID: 4127172
    [No Abstract]   [Full Text] [Related]  

  • 53. Enzymatic changes in various organs of guinea pigs caused by the administration of Freund's complete adjuvant.
    Aoyagi T; Wada T; Nishikiori T; Kojima F; Nagai M; Osanai T; Nagai Y; Umezawa H
    J Pharmacobiodyn; 1983 Dec; 6(12):974-82. PubMed ID: 6201605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
    Javed NH; Gienapp I; Cox K; Whitacre CC
    Ann N Y Acad Sci; 1996 Feb; 778():393-4. PubMed ID: 8611001
    [No Abstract]   [Full Text] [Related]  

  • 55. Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein.
    Swanborg RH
    J Immunol; 1972 Sep; 109(3):540-6. PubMed ID: 4626655
    [No Abstract]   [Full Text] [Related]  

  • 56. STRAIGHT CHAIN HYDROCARBONS AS SUBSTITUTES FOR THE OIL IN FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    SHAW CM; ALVORD EC; KIES MW
    J Immunol; 1964 Jan; 92():24-7. PubMed ID: 14139542
    [No Abstract]   [Full Text] [Related]  

  • 57. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AN ANALYSIS OF COMPONENTS OF FREUND'S ADJUVANTS IN THE PRODUCTION OF EXPERIMENTAL "ALLERGIC" ENCEPHALOMYELITIS IN THE GUINEA PIG.
    ALVORD EC; SHAW CM; FAHLBERG WJ; KIES MW
    Z Immunitats Allergieforsch; 1964 Mar; 126():193-208. PubMed ID: 14185397
    [No Abstract]   [Full Text] [Related]  

  • 59. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant.
    Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
    Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
    Keith AB; Arnon R; Teitelbaum D; Caspary EA; Wisniewski HM
    J Neurol Sci; 1979 Jul; 42(2):267-74. PubMed ID: 90129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.